CTOs on the Move


 
LENSAR, Inc. is a global leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision, accuracy, and efficiency while optimizing overall visual outcomes. LENSAR`s proprietary Augmented Reality technology -- reconstructed 3-D imaging, measurement, and guidance system -- offers quick and easy patient docking and provides high-resolution ocular images in a single scan. This technology facilitates enhanced procedure outcomes by allowing the physician to develop individualized treatment plans including precise laser delivery, and efficient lens fragmentation that can reduce, and potentially eliminate phaco energy. The LENSAR Laser System also offers the industry`s smallest ...
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million
  • www.lensar.com
  • 2800 Discovery Drive
    Orlando, FL USA 32826
  • Phone: 888.536.7271

Executives

Name Title Contact Details

Similar Companies

TELA Bio

TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient`s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient`s natural healing response while minimizing long-term exposure to permanent synthetic materials.

Virginia Home Medical

Virginia Home Medical is a Virginia Beach, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medcare Products

Medcare Products is a Burnsville, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Koya

Koya Medical is a transformative healthcare venture with a mission to treat cancer-related chronic lymphedema and venous diseases through innovative patient-centric platforms.

Essilor

The world`s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To support this mission, Essilor allocates more than €200 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Transitions®, Eyezen™, Xperio®, Foster Grant®, Bolon™ and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals. Essilor reported consolidated revenue of more than €7.1 billion in 2016 and employs 64,000 people worldwide. It markets its products in more than 100 countries and has 33 plants, 490 prescription laboratories and edging facilities, as well as five research and development centers around the world.